News Events
November 2, 2010
Escape secures exclusive license with Stanford University for a novel bone growth protein.
Escape signed an exclusive worldwide license agreement with Stanford University to commercialize a novel patent-pending osteogenic differentiation protein. Research at Stanford University has yielded a novel method to engineer bone from mesenchymal stem cells. The investigator, Dr. Basil M. Hantash, an Instructor in the Division of Plastic Surgery at Stanford University, and colleague Dr. Longmei Zhao have discovered a physiologically relevant method to induce osteogenic differentiation that circumvents the need for steroids which suppress wound healing in vivo. This new discovery has the potential to significantly advance the treatment of bone injuries such as acute fractures.